Boosting testosterone: Gencor unveils ingredient for men’s anti-aging and sports nutrition
17 Sep 2020 --- Gencor has released a new ingredient that boasts anti-aging and sports nutrition potential for men. Tesnor is an herbal combination of cocoa bean and pomegranate peel extracts that can increase in-cell testosterone production and inhibits aromatase activity, according to the company.
“We expect Tesnor to be a strong contender in the men’s health marketplace due to its numerous application formats,” says Chase Shryoc, vice president of sales and business development at Gencor.
Daily doses of Tesnor have been studied for improvement in testosterone as well as for reducing Aging Male Symptoms (AMS) scores. “We look forward to sharing the positive results demonstrated in clinical studies for both young and aging males,” Shryoc adds.
The ingredient is marketed as a food-derived, standardized and IP protected testosterone-boosting extract.
“Tesnor is a well-researched ingredient with an excellent safety profile that meets global regulations,” Shryoc notes.
“It has been tested with the National Science Foundation (NSF) and the Laboratory of the Government Chemist (LGC) for absence of World Anti-Doping Agency (WADA) prohibited substances. It also offers versatility in its ability to be applied in a variety of formats to meet the on-to-go consumer demands,” he adds.
The health aging question
Industry is seeing growing interest in men’s health and sports boosting NPD. A recent Innova Market Insights survey revealed that consumers are increasingly seeking a more holistic approach to healthy aging.
The research reveals that seven out of ten consumers have made changes across the past year to improve their health. These changes were not just for physical health, but also focused on balancing physical, mental and emotional aspects.
Especially in the supplements space, specificity is increasingly important, with more general Health & Wellness claims losing their share over 2015-2019, according to Innova Market Insights data.
However, it is specific health benefits that are becoming more prominent, with gender-specific positioning losing some ground since 2015. Anti-aging and mental well-being are growing areas of attention, with mental acuity and skin health products gaining significant share within NPD. Insomnia is another expanding focus alongside brain and mood issues.
The market researcher’s data show that among claims, gender focus is less important but present, with 2019 seeing a 5.2 percent market share in women’s health NPD and a 2.5 percent for men’s health launches.
Spotlight on men’s health
In the men’s health space, Gencor also launched a fenugreek extract, coined Testofen. It can increase strength, aerobic endurance and lean body mass in healthy, exercising men.
PLT Health Solutions introduced a new low-dose, botanically-based ingredient for sports and active nutrition. The Ayurvedic-inspired blend called RipFactor Muscle Accelerator is made from flower heads and tree bark. According to the company, the new ingredient delivers results for muscle growth, vasodilation, endurance and strength within 14 days.
Meanwhile, IFF Health’s Go-Less Men plant-based ingredient for healthy bladder function in men recently received Non-GMO Project Verified certification. Go-Less Men is based on bioactive components found in pumpkin seeds.
Lycrored also addressed urinary and sleep issues in men with the launch of LycoComfort. Made with standardized tomato extract and natural phytosterols, the offering is touted as aiding holistic wellness.
In the same arena, UK-based nutraceutical company Sibelius Natural Products launched a proprietary lycopene extract coined Sibelius: LactoMato. The extract is a tomato oleoresin-based formulation backed by multiple clinical studies demonstrating its ability to help support male reproductive health, prostate health and cardiovascular health.
Edited by Kristiana Lalou
To contact our editorial team please email us at editorial@cnsmedia.com
Subscribe now to receive the latest news directly into your inbox.